Vaccinotherapy in renal cell carcinoma

Dariusz W. Kowalczyk

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

3/2007
vol. 11

Send email

Copy url:

abstract:

Vaccinotherapy in renal cell carcinoma

Dariusz W. Kowalczyk

Współczesna Onkologia (2007) vol. 11; 3 (160–166)

Online publish date: 2007/04/26

View full text Get citation

Renal cell carcinoma is resistant to classical radiotherapy or chemotherapy. On the other hand these tumors seem to be immunogenic which make them potentially susceptible to immunotherapeutic approaches including anti-cancer vaccines. This article presents an analysis of recent publications on vaccine based treatments of renal cell carcinoma. Through Medline search 41 clinical trials were identified involving 1094 patients. Tested vaccines were composed of tumor cells, tumor lysates, dendritic cells, peptides or heat shock proteins. Clinical response data were presented for 657 patients with advanced (stage IV) cancer. Objective response was observed in about 27.4% of these patients: 20 patients showed complete response (CR) (3.0%), 36 partial response (PR) (5.5%), 10 mixed response (MR) (1.5%) and 114 had stable disease (SD) (17.4%). It appears that active, vaccine based immunotherapy may induce anti-tumor immune reaction in selected group of patients leading to moderate clinical responses.

keywords:

Vaccinotherapy in renal cell carcinoma

Dariusz W. Kowalczyk

renal cell carcinoma, kidney cancer, vaccines, immunotherapy, clinical trials